Overview
- The DAX has surged to 22,140 points, completing a sharp V-shaped recovery from early April lows of 18,489, but faces resistance at 22,200.
- Hopes for U.S.-China trade de-escalation persist, with President Trump asserting ongoing negotiations despite Beijing's denials.
- U.S. equity markets rallied, with the Dow Jones, S&P 500, and Nasdaq gaining 1.2%, 2.0%, and 2.7%, respectively, on trade optimism and potential rate cuts.
- Merck is advancing talks to acquire U.S.-based Springworks Therapeutics for approximately $47 per share, signaling a major M&A move in the pharmaceutical sector.
- T-Mobile US and Intel reported disappointing results, with weaker-than-expected subscriber growth and revenue forecasts, weighing on their respective stocks.